Clinical Trials

Phase 2 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02873962 2026-04-01

A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib

72 enrolled 16 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05116189 2026-03-09

KEYNOTE-B96

643 enrolled 17 charts 3 FDA

Phase 1/2 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02734004 2026-01-29

MEDIOLA

264 enrolled 32 charts

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT00565851 2025-12-30

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

1,052 enrolled 27 charts

Brenner Tumor, Carcinoma, Adenocarcinoma, Mucinous, Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell

NCT02364713 2025-12-11

MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer

17 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01081262 2025-11-25

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

50 enrolled 13 charts

Phase 1 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02142803 2025-11-13

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

50 enrolled 16 charts

CNSGynecologic

Fallopian Tube Neoplasms, Glioblastoma, Ovarian Neoplasms

NCT03740165 2025-10-22

KEYLYNK-001

1,367 enrolled 29 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT05446870 2025-10-01

MK-4830-002

160 enrolled 19 charts

Ovarian Neoplasms

NCT03326193 2025-07-31

A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

105 enrolled 29 charts

Ovarian Neoplasms

NCT03574779 2025-07-15

OPAL

77 enrolled 8 charts

Ovarian Neoplasms

NCT02312245 2024-12-05

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

13 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03635489 2024-10-03

A Study of the Efficacy and Safety of Bevacizumab in Chinese Women With Newly Diagnosed, Previously Untreated Stage III or Stage IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

100 enrolled 22 charts

GastrointestinalGynecologicThoracic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03250832 2024-04-11

CITRINO

Phase 1 Completed

111 enrolled 48 charts

Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02923739 2024-03-13

Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

9 enrolled 9 charts

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05751629 2023-04-21

COHORT-A

41 enrolled 17 charts

Ovarian Neoplasms

NCT03038100 2023-02-17

IMagyn050

1,301 enrolled 22 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04753216 2023-01-19

Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

3 enrolled 15 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01097746 2022-10-28

First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

33 enrolled 10 charts

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00976911 2022-06-21

AURELIA: A Study of Avastin (Bevacizumab) Added to Chemotherapy in Patients With Platinum-resistant Ovarian Cancer

361 enrolled 15 charts

Ovarian Neoplasms

NCT00886691 2022-02-04

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

150 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01551745 2021-10-19

Salvage Ovarian FANG™ Vaccine + Bevacizumab

5 enrolled 9 charts

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02853318 2021-10-06

Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

40 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03394885 2021-08-12

AdORN

Phase 1/2 Completed

18 enrolled 15 charts

Ovarian Neoplasms

NCT00436215 2020-11-23

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

55 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02661815 2019-11-08

A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer

Phase 1 Terminated

6 enrolled 8 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01305213 2019-07-30

Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

107 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00262847 2019-07-23

Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

1,873 enrolled 17 charts 2 FDA

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01010126 2019-01-25

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

GastrointestinalGynecologic

252 enrolled 20 charts

Fallopian Tube Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Somatostatinoma

NCT00856180 2018-09-10

Sequential Angiogenic Blockade for the Treatment of Recurrent Mullerian Malignancies

20 enrolled 9 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00520013 2018-07-27

Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors

60 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01223235 2018-06-12

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

Phase NA Completed

22 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00866723 2018-05-22

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer

5 enrolled 6 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00408070 2018-03-08

Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer

5 enrolled 7 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT01936974 2018-02-20

PGA

7 enrolled 1 chart

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01219777 2018-02-08

Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian

Phase 1 Completed

9 enrolled 7 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00937560 2017-11-06

A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer

190 enrolled 8 charts

Ovarian Neoplasms

NCT00434642 2017-08-09

OCEANS

484 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00511992 2017-07-02

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer

20 enrolled 9 charts

Ovarian Neoplasms

NCT01248949 2017-03-29

A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Phase 1 Completed

162 enrolled 21 charts

CNSGynecologic

Glioma, Ovarian Neoplasms

NCT00545792 2017-03-15

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

21 enrolled 9 charts

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT01031381 2016-08-30

RADBEV

50 enrolled 7 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Recurrence

NCT01239732 2016-06-10

A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer

1,021 enrolled 11 charts

Ovarian Neoplasms

NCT00129727 2016-06-01

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

62 enrolled 9 charts

Neoplasms, Ovarian Neoplasms

NCT00588237 2016-01-20

Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

42 enrolled 6 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01091259 2015-11-24

Irinotecan and Bevacizumab for Recurrent Ovarian Cancer

29 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00945139 2015-07-31

Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA)

46 enrolled 11 charts

Ovarian Neoplasms

NCT00343044 2015-05-15

Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers

40 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00072566 2015-05-12

Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

70 enrolled 7 charts